Human IBD-on-a-Chip Identifies Fibroblasts as Main Disease Driver, Raising 30%-35% Pregnancy Flare Insight
Updated
Updated · Nature.com · May 21
Human IBD-on-a-Chip Identifies Fibroblasts as Main Disease Driver, Raising 30%-35% Pregnancy Flare Insight
3 articles · Updated · Nature.com · May 21
Researchers built a human colon-on-a-chip from patient-derived cells that reproduced key IBD features, including weaker barrier function, less mucus, higher inflammation, fibrosis and greater sensitivity to cancer-linked changes.
Heterotypic tissue tests showed IBD fibroblasts—not the epithelium alone—were the main trigger of barrier disruption and inflammatory signals such as IL-6 and MCP-1, while also promoting immune-cell migration.
Peristalsis-like strain worsened the disease state in IBD chips, sharply increasing collagen buildup, leakiness and inflammatory gene activity, while healthy chips mainly boosted protective mucus production.
Female-hormone exposure intensified fibrosis and inflammatory cytokines in female-derived IBD chips, offering a mechanistic clue for symptom worsening during pregnancy, which affects about 30%-35% of women with IBD.
After 3 weeks of ENU exposure at 10 μg/ml, IBD chips showed more mutations, chromosome amplifications and early colorectal-cancer markers than healthy chips, suggesting the platform could help study progression and test personalized therapies.
If a chip can now mimic IBD, how long until it can predict a patient's personal disease course?
This model blames fibroblasts for IBD. Does this challenge the long-held focus on immune cells as the primary culprits?
With technology now replicating human disease in a lab, is this the beginning of the end for animal testing?
Decoding IBD’s Core Mechanisms: Organ-on-a-Chip Insights into Stroma, Mechanical Forces, and Pregnancy Hormones
Overview
Recent advancements in human organ-on-a-chip technology have enabled researchers to create sophisticated colon-on-a-chip devices using patient-derived cells from both healthy individuals and those with IBD. These models successfully mimic real-life gut conditions and have been crucial in uncovering how stromal fibroblasts, especially within the stroma, interact with the epithelium, immune cells, fluid flow, and mechanical forces. This approach has provided a much clearer understanding of the fundamental mechanisms driving IBD, highlighting the stroma as a key driver of disease and paving the way for new therapeutic strategies.